All Stories

  1. Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study

    Article • Journal of Cardiovascular Pharmacology and Therapeutics, April 2018, SAGE Publications

    Endalkahcew Admassie

  2. Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation

    Article • The American Journal of Cardiology, October 2017, Elsevier

    Endalkahcew Admassie

  3. Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) study

    Article • European Journal of Clinical Pharmacology, September 2017, Springer Science + Business Media

    Endalkahcew Admassie

  4. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015

    Article • Cardiovascular Therapeutics, May 2017, Wiley

    Endalkahcew Admassie

  5. Subchronic administration of Catha edulis F. (khat) extract is marked by elevation of cardiac biomarkers and subendocardial necrosis besides blood pressure alteration in rats

    Article • Journal of Ethnopharmacology, June 2011, Elsevier

    Endalkahcew Admassie